Ublituximab: A Novel Anti-CD20 Therapy for Multiple Sclerosis

Authors
Category Primary study
JournalUS Neurology
Year 2023
This article has no abstract
Epistemonikos ID: 76d4fb7a2b867da6e43995cda4425833625a0912
First added on: Feb 16, 2025